0001209191-19-032054.txt : 20190522 0001209191-19-032054.hdr.sgml : 20190522 20190522162500 ACCESSION NUMBER: 0001209191-19-032054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190520 FILED AS OF DATE: 20190522 DATE AS OF CHANGE: 20190522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRYNJELSEN SEAN CENTRAL INDEX KEY: 0001669976 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38738 FILM NUMBER: 19846069 MAIL ADDRESS: STREET 1: C/O ETON PHARMACEUTICALS, INC. STREET 2: 21925 W FIELD PKWY #235 CITY: DEER PARK STATE: IL ZIP: 60010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eton Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001710340 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 371858472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21925 W. FIELD PARKWAY STREET 2: SUITE 235 CITY: DEER PARK STATE: IL ZIP: 60010-7208 BUSINESS PHONE: (847) 787-7361 MAIL ADDRESS: STREET 1: 21925 W. FIELD PARKWAY STREET 2: SUITE 235 CITY: DEER PARK STATE: IL ZIP: 60010-7208 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-20 0 0001710340 Eton Pharmaceuticals, Inc. ETON 0001669976 BRYNJELSEN SEAN 21925 W FIELD PKWY #235 DEER PARK IL 60010 1 1 0 0 President & CEO Common Stock 2019-05-20 4 P 0 1400 7.782 A 1011400 D Common Stock 2019-05-21 4 P 0 8600 7.9571 A 1020000 D Common Stock 24940 I By LLC The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.77 to $7.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. /s/ W. Wilson Troutman, Attorney-in-fact 2019-05-22